摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Amino-2,2,8,8-tetramethylnonane-3,7-dione

中文名称
——
中文别名
——
英文名称
4-Amino-2,2,8,8-tetramethylnonane-3,7-dione
英文别名
4-amino-2,2,8,8-tetramethylnonane-3,7-dione
4-Amino-2,2,8,8-tetramethylnonane-3,7-dione化学式
CAS
——
化学式
C13H25NO2
mdl
——
分子量
227.34
InChiKey
BYQXVMAOYDTINQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    60.2
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISORDERS
    申请人:Kandula Mahesh
    公开号:US20150133407A1
    公开(公告)日:2015-05-14
    The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of respiratory disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of viscid or excessive mucus, cough, inflammation, redness in sore throat, infection in the throat, sore throat, abnormal mucus secretion, impaired mucus transport, allergic rhinitis, asthma, COPD, respiratory muscular disorders and pain in acute sore throat.
    本发明涉及公式I的化合物或其药用可接受的盐,以及它们的聚合物、溶剂化物、对映体、立体异构体和合物。包含有效量的公式I化合物的药物组合物,以及用于治疗呼吸系统疾病的方法,可以口服、颊部、直肠、局部、经皮、经粘膜、静脉、非肠道给药、糖浆或注射剂的形式制备。此类组合物可用于治疗粘性或过量粘液、咳嗽、喉咙痛的红肿、喉咙感染、喉咙痛、异常粘液分泌、粘液运输受损、过敏性鼻炎、哮喘、慢性阻塞性肺病(COPD)、呼吸肌疾病和急性喉咙痛的疼痛。
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF COUGH
    申请人:Kandula Mahesh
    公开号:US20150133533A1
    公开(公告)日:2015-05-14
    The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for treating or preventing cough may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of acute respiratory tract infections, asthma, gout, fibromyalgia, facilitating conception, promotes secondary mucosal secretions in the respiratory system, muscle relaxant, allergy, asthma, chronic obstructive pulmonary disorders, spasms, respiratory and neurological diseases.
    该发明涉及公式I的化合物或其药用可接受的盐,以及其多晶型、溶剂合物、对映体、立体异构体和合物。包括有效量的公式I化合物的药物组合物,以及用于治疗或预防咳嗽的方法可以制备为口服、颊内、直肠、局部、经皮、经粘膜、静脉、肠道给药、糖浆或注射。这种组合物可用于治疗急性呼吸道感染、哮喘、痛风、纤维肌痛、促进受孕、促进呼吸系统中的次级粘膜分泌、肌肉松弛剂、过敏、哮喘、慢性阻塞性肺疾病、痉挛、呼吸和神经系统疾病。
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION AND LIPID DISORDERS
    申请人:Kandula Mahesh
    公开号:US20150057347A1
    公开(公告)日:2015-02-26
    The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II; and methods for treating or preventing inflammation and lipid disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of hypertriglyceridemia, steatohepatitis, cystinosis and inflammatory diseases.
    该发明涉及公式I和公式II的化合物或其药用可接受的盐,以及其多晶型、溶剂合物、对映体、立体异构体和合物。包括有效量的公式I或公式II化合物的药物组合物;以及用于治疗或预防炎症和脂质紊乱的方法可以制成口服、颊内、直肠、局部、经皮、经粘膜、静脉、肠道给药、糖浆或注射剂。这种组合物可用于治疗高三酸甘油酯血症、脂肪肝、半胱酸症和炎症性疾病。
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    申请人:Kandula Mahesh
    公开号:US20160122332A1
    公开(公告)日:2016-05-05
    The invention relates to the compounds of formula I and formula IA or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I and formula IA; and methods for treating or preventing neurological diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of epilepsy, bipolar disorder, trigeminal neuralgia, attention-deficit hyperactivity disorder (ADHD), schizophrenia, neuropathic pain, seizures, bipolar disorder, mania, phantom limb syndrome, complex regional pain syndrome, paroxysmal extreme pain disorder, neuromyotonia, intermittent explosive disorder, borderline personality disorder, Myotonia congenita and post-traumatic stress disorder.
    该发明涉及公式I和公式IA的化合物或其药用可接受盐,以及其多晶型、溶剂合物、对映体、立体异构体和合物。包括有效量的公式I和公式IA化合物的药物组合物;以及用于口服、颊内、直肠、局部、经皮、经粘膜、静脉内、肠外给药、糖浆或注射的治疗或预防神经系统疾病的方法。这些组合物可用于治疗癫痫、躁郁症、三叉神经痛、注意缺陷多动障碍(ADHD)、精神分裂症、神经痛、癫痫发作、躁郁症、狂躁症、幻肢综合征、复杂性区域性疼痛综合征、阵发性极端疼痛综合征、神经肌痉挛、间歇性爆发障碍、边缘人格障碍、先天性肌张力过高症和创伤后应激障碍。
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE PAIN
    申请人:Kandula Mahesh
    公开号:US20150152081A1
    公开(公告)日:2015-06-04
    The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of severe pain may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of chronic pain, generalized pain disorders, leukemia, cancer, chronic pain, chemotherapy induced pain, epilepsy, migraine, neuropathic pain, post herpetic neuralgia, neuralgia, pain, drug addiction, detoxification of drugs, Alzheimer's disease, multiple sclerosis, multiple sclerosis, restless legs syndrome (RLS), cluster headache, depression, fibromyalgia, amyotrophic lateral sclerosis (ALS), convulsions, partial seizures, mood-stabilizing agent and bipolar disorder.
    该发明涉及公式I的化合物或其药用可接受盐,以及其多晶型、溶剂合物、对映体、立体异构体和合物。包括有效量的公式I化合物的药物组合物,以及用于治疗严重疼痛的方法可以制成口服、颊内、直肠、局部、经皮、经粘膜、静脉、肠道给药、糖浆或注射剂。这种组合物可用于治疗慢性疼痛、广泛性疼痛障碍、白血病、癌症、化疗引起的疼痛、癫痫、偏头痛、神经痛、带状疱疹后神经痛、神经痛、疼痛、药物成瘾、药物戒断、阿尔茨海默病、多发性硬化症、多发性硬化症、不宁腿综合征(RLS)、集束性头痛、抑郁症、纤维肌痛、肌萎缩侧索硬化症(ALS)、抽搐、部分性癫痫、情绪稳定剂和躁郁症的治疗。
查看更多